Maor M, Chan R C, Young S E
Cancer. 1977 Nov;40(5):2081-6. doi: 10.1002/1097-0142(197711)40:5<2081::aid-cncr2820400515>3.0.co;2-o.
Forty-two cases of metastatic breast cancer to the choroid treated by radiation therapy were reviewed. Fifteen patients (36%) had bilateral and 27 patients (64%) had unilateral choroidal involvement. In 12 patients (29%) the choroid was the first site of dissemination. The median survival period after choroidal metastases was 10 months. Most patients were treated with Co60 in doses of 2500 rads tumor dose (TD) in ten fractions, 2500 rads, (TD) in five fractions and 3000 rads (TD) in ten fractions. An early group of patients had orthovoltage therapy. Good visual responses were obtained with each of the above treatment programs. Radiation treatment in the range of 2500-3000 rads TD in a short course is recommended for palliation of metastatic breast cancer to the choroid.
回顾了42例接受放射治疗的脉络膜转移性乳腺癌患者。15例患者(36%)为双侧脉络膜受累,27例患者(64%)为单侧脉络膜受累。12例患者(29%)脉络膜是首个转移部位。脉络膜转移后的中位生存期为10个月。大多数患者接受钴60治疗,肿瘤剂量(TD)为2500拉德,分10次照射;2500拉德,分5次照射;以及3000拉德,分10次照射。早期一组患者接受了深部X线治疗。上述每种治疗方案均获得了良好的视觉反应。对于脉络膜转移性乳腺癌的姑息治疗,建议短疗程给予2500 - 3000拉德TD范围的放射治疗。